Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
24 pending office actions • 16 art units • 23 examiners • 0 of 24 (0%) have an AI response strategy ready • 16 patents granted in the last 365 days
Technische Universität München maintains a portfolio with 23 pending office actions, primarily focused within the Biotechnology & Pharmaceuticals technology area. This volume is distributed across 22 distinct examiners, indicating a decentralized prosecution strategy where individual examiner tendencies vary. The involvement of 16 distinct art units further suggests a broad technical scope within the university's research output, requiring practitioners to adapt to many different departmental standards.
SYLVESTER, KEVIN serves as the busiest examiner for this portfolio, currently managing 2 pending office actions. While this represents the highest concentration for a single official, the remaining matters are spread among other examiners. This distribution means that 22 distinct examiners are influencing the outcome of the 23 pending actions, leaving little room for examiner-specific trends to dominate the overall portfolio strategy. Practitioners should prepare for diverse procedural requirements given that the 16 distinct art units represent a high degree of departmental variety across the biotechnology sector.
The count of 16 distinct art units relative to the total workload implies that the university's biotechnology and pharmaceutical filings are not concentrated in a single niche but are instead spread across various specialized divisions. This complexity necessitates a case-by-case approach to prosecution, as the 22 distinct examiners will likely apply different levels of rigor based on their specific art unit's guidelines. Successfully navigating these matters will require a deep understanding of the unique technical and administrative expectations of each involved department.
Based on the USPTO statutory response window for each pending office action. 9 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 9 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 8 (33%) |
| §102 only | 1 (4%) |
| §112 only | 1 (4%) |
| Double-patenting + other | 2 (8%) |
| Multi-statute (no §101) | 12 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SYLVESTER, KEVIN | 2 | 47.5% | +27.4% |
| QURESHI, MOHAMMED AHMED | 1 | 82.7% | +13.4% |
| BUKSA, CHRISTOPHER ALLEN | 1 | 73.6% | +20.1% |
| WRIGHT, ALEXANDER SCOTT | 1 | 73.5% | -0.6% |
| GROUX, JENNIFER LILA | 1 | 34.8% | +39.3% |
| ROBINSON, HOPE A | 1 | 67.7% | +43.1% |
| LANGHALS, RENEE C | 1 | 58.3% | +43.0% |
| ORDUNA, TAMARA | 1 | — | — |
| DODDS, SCOTT | 1 | 68.1% | +34.5% |
| LANKFORD JR, LEON B | 1 | 70.0% | +31.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18029516 | BIOORTHOGONAL REPORTER GENE SYSTEM | BATES, KEENAN ALEXANDER | 18d overdue |
| 18682872 | FLUID VESSEL AND MANUFACTURING METHOD FOR A FLUID VESSEL | DODDS, SCOTT | 16d overdue |
| 18711692 | MULTI-DIMENSIONAL TOOL ADJUSTMENT BASED ON ACOUSTIC SIGNAL | LANGHALS, RENEE C | 15d overdue |
| 18832700 | METHOD AND DEVICE FOR ADDITIVELY MANUFACTURING AN OBJECT | GROUX, JENNIFER LILA | 15d |
| 18863057 | AC-FIELD DRIVEN MACROMOLECULAR ROTARY MOTOR | QURESHI, MOHAMMED AHMED | — |
| 18833309 | MANUFACTURING DEVICE FOR MANUFACTURING OBJECTS IN LAYERS | WRIGHT, ALEXANDER SCOTT | — |
| 18719148 | A METHOD FOR GENETIC MODIFICATION FOR HIGH GC CONTENT MICROORGANISMS | ROBINSON, HOPE A | — |
| 18280325 | TREATMENT OF CORONAVIRUS INFECTIONS USING SAM CYCLE INHIBITORS | NEAGU, IRINA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18862947 | MODULAR ROBOTIC SYSTEM | BUKSA, CHRISTOPHER ALLEN | 31d overdue |
| 18269359 | COATED MEMBRANE FOR WATER ELECTROLYSIS | SYLVESTER, KEVIN | 23d overdue |
| 18682872 | FLUID VESSEL AND MANUFACTURING METHOD FOR A FLUID VESSEL | DODDS, SCOTT | 16d overdue |
| 18711692 | MULTI-DIMENSIONAL TOOL ADJUSTMENT BASED ON ACOUSTIC SIGNAL | LANGHALS, RENEE C | 15d overdue |
| 18832700 | METHOD AND DEVICE FOR ADDITIVELY MANUFACTURING AN OBJECT | GROUX, JENNIFER LILA | 15d |
| 18863057 | AC-FIELD DRIVEN MACROMOLECULAR ROTARY MOTOR | QURESHI, MOHAMMED AHMED | — |
| 18719148 | A METHOD FOR GENETIC MODIFICATION FOR HIGH GC CONTENT MICROORGANISMS | ROBINSON, HOPE A | — |
| 18291943 | DETECTION OF MOLECULAR BIOLOGICAL OBJECTS, CELLULAR BIOLOGICAL OBJECTS AND CELL AGGREGATES USING QUANTITATIVE PHASE-CONTRAST MICROSCOPY | LANKFORD JR, LEON B | — |
| Art Unit | Apps |
|---|---|
| 1612 | 3 |
| 1618 | 2 |
| 1794 | 2 |
| 3658 | 1 |
| 1745 | 1 |
| 1754 | 1 |
| 1652 | 1 |
| 3797 | 1 |
| 1746 | 1 |
| 1657 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18863057 | AC-FIELD DRIVEN MACROMOLECULAR ROTARY MOTOR | QURESHI, MOHAMMED AHMED | — | §102§103§112 | Non-Final OA | — | Pending | Nov 05, 2024 |
| 18862947 | MODULAR ROBOTIC SYSTEM | BUKSA, CHRISTOPHER ALLEN | 3658 | §103 | Final Rejection | 31d overdue | Pending | Nov 04, 2024 |
| 18833309 | MANUFACTURING DEVICE FOR MANUFACTURING OBJECTS IN LAYERS | WRIGHT, ALEXANDER SCOTT | 1745 | §102§103§112 | Final Rejection | — | Pending | Jul 25, 2024 |
| 18832700 | METHOD AND DEVICE FOR ADDITIVELY MANUFACTURING AN OBJECT | GROUX, JENNIFER LILA | 1754 | §102§103 | Final Rejection | 15d | Pending | Jul 24, 2024 |
| 18719148 | A METHOD FOR GENETIC MODIFICATION FOR HIGH GC CONTENT MICROORGANISMS | ROBINSON, HOPE A | 1652 | §103§112 | Final Rejection | — | Pending | Jun 12, 2024 |
| 18711692 | MULTI-DIMENSIONAL TOOL ADJUSTMENT BASED ON ACOUSTIC SIGNAL | LANGHALS, RENEE C | 3797 | §103§112 | Non-Final OA | 15d overdue | Pending | May 20, 2024 |
| 18690856 | PROCESS FOR THE MANUFACTURE OF A COATED CATHODE ACTIVE MATERIAL, AND COATED CATHODE ACTIVE MATERIAL | ORDUNA, TAMARA | — | §103 | Final Rejection | — | Pending | Mar 11, 2024 |
| 18682872 | FLUID VESSEL AND MANUFACTURING METHOD FOR A FLUID VESSEL | DODDS, SCOTT | 1746 | §103§112 | Non-Final OA | 16d overdue | Pending | Feb 09, 2024 |
| 18291943 | DETECTION OF MOLECULAR BIOLOGICAL OBJECTS, CELLULAR BIOLOGICAL OBJECTS AND CELL AGGREGATES USING QUANTITATIVE PHASE-CONTRAST MICROSCOPY | LANKFORD JR, LEON B | 1657 | §103 | Non-Final OA | — | Pending | Jan 25, 2024 |
| 18291952 | DETECTION OF CELL AGGREGATES USING QUANTITATIVE PHASE-CONTRAST MICROSCOPY | BAYNES, SAMUEL DAVID | 2665 | §103Other | Final Rejection | 4d overdue | Pending | Jan 25, 2024 |
| 18570451 | PORTABLE TESTING DEVICE FOR TESTING SUSCEPTIBILITY OF A BIOLOGICAL PROBE TO ONE OR MORE BIOACTIVE SUBSTANCES | BOWERS, NATHAN ANDREW | — | §103 | Final Rejection | — | Pending | Dec 14, 2023 |
| 18286003 | NUCLEIC ACID ORIGAMI PLATFORMS AND THEIR USES | SCHLIENTZ, LEAH H | 1618 | §102 | Non-Final OA | — | Pending | Oct 06, 2023 |
| 18280325 | TREATMENT OF CORONAVIRUS INFECTIONS USING SAM CYCLE INHIBITORS | NEAGU, IRINA | 1629 | §102§103§112 | Non-Final OA | — | Pending | Sep 05, 2023 |
| 18546311 | DUAL MODE RADIOTRACER AND THERAPEUTICS | MOSHER, ERIC PARKER | 1612 | §112Other | Non-Final OA | 28d | Pending | Aug 14, 2023 |
| 18276802 | CXCR4-LIGANDS FOR DIAGNOSTIC AND THERAPEUTIC USE AND PRECURSORS THEREOF | RONEY, CELESTE A | 1612 | §103§112DP | Non-Final OA | — | Pending | Aug 10, 2023 |
| 18269359 | COATED MEMBRANE FOR WATER ELECTROLYSIS | SYLVESTER, KEVIN | 1794 | §103 | Final Rejection | 23d overdue | Pending | Jun 23, 2023 |
| 18269088 | CONDITIONAL CELL CONNECTORS | KIM, YUNSOO | 1641 | §102§103DP | Non-Final OA | — | Pending | Jun 22, 2023 |
| 18256101 | IRIDIUM-CONTAINING CATALYST FOR WATER ELECTROLYSIS | SYLVESTER, KEVIN | 1794 | §103§112 | Non-Final OA | — | Pending | Jun 06, 2023 |
| 18252861 | NETWORK STATE MODELLING | ALHIJA, SAIF A | — | §102§112 | Non-Final OA | — | Pending | May 12, 2023 |
| 18031759 | METHANATION WITH TURBOCHARGER | LEUNG, JENNIFER A | 1774 | §103§112 | Non-Final OA | — | Pending | Apr 13, 2023 |
| 18029516 | BIOORTHOGONAL REPORTER GENE SYSTEM | BATES, KEENAN ALEXANDER | 1631 | §102§103§112 | Final Rejection | 18d overdue | Pending | Mar 30, 2023 |
| 17910728 | CYCLIC PEPTIDES AND THEIR CONJUGATES FOR ADDRESSING ALPHA-V-BETA-6 INTEGRIN IN VIVO | WEBB, WALTER E | 1612 | §103 | Final Rejection | 37d overdue | Pending | Sep 09, 2022 |
| 17770764 | Theragnostic Endoprosthetic Spacer | DUDDEN, TERESA MARIE | 3774 | §103§112 | Non-Final OA | — | Pending | Apr 21, 2022 |
| 17768706 | COMPOUNDS WITH IMPROVED PHARMACOKINETICS FOR IMAGING AND THERAPY OF CANCER | PERREIRA, MELISSA JEAN | 1618 | §103 | Non-Final OA | — | Pending | Apr 13, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial